The doses of TFV and TAF used in Fig. 1 are very efficient at suppressing HIV infection of CD4+ T cells in vitro, and therefore could mask any potential modifications of ARV effectiveness by contraceptives. The gene discussed is CD4; the disease is HIV infectious disease.